161 related articles for article (PubMed ID: 8112958)
21. Prevalence of ovarian endometriosis in epithelial ovarian cancer.
Jimbo H; Yoshikawa H; Onda T; Yasugi T; Sakamoto A; Taketani Y
Int J Gynaecol Obstet; 1997 Dec; 59(3):245-50. PubMed ID: 9486515
[TBL] [Abstract][Full Text] [Related]
22. Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California.
Mills PK; Riordan DG; Cress RD; Young HA
Int J Cancer; 2004 Nov; 112(3):458-64. PubMed ID: 15382072
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
[TBL] [Abstract][Full Text] [Related]
25. Structural changes and cell properties of human ovarian surface epithelium in ovarian pathophysiology.
Okamura H; Katabuchi H; Nitta M; Ohtake H
Microsc Res Tech; 2006 Jun; 69(6):469-81. PubMed ID: 16718660
[TBL] [Abstract][Full Text] [Related]
26. A case-control study of borderline ovarian tumors: the influence of perineal exposure to talc.
Harlow BL; Weiss NS
Am J Epidemiol; 1989 Aug; 130(2):390-4. PubMed ID: 2750733
[TBL] [Abstract][Full Text] [Related]
27. [Incidence of synchronous primary neoplasms of the female reproductive tract in women with ovarian endometriosis: a retrospective analysis of 811 cases].
Grammatikakis I; Ivanov S; Evangelinakis N; Zevoudis S; Tziortzioti V
Akush Ginekol (Sofiia); 2009; 48(3):26-30. PubMed ID: 20198760
[TBL] [Abstract][Full Text] [Related]
28. Endometriosis and other benign and malignant müllerian lesions in pelvic and extrapelvic organs.
Lambrinoudaki I; Augoulea A; Creatsa M; Vlachos N; Christodoulakos G; Papadias C
Anal Quant Cytol Histol; 2009 Jun; 31(3):170-6. PubMed ID: 19634787
[TBL] [Abstract][Full Text] [Related]
29. The occurrence of endometriosis with ovarian carcinomas is not purely coincidental.
Qiu L; Wang S; Lang JH; Shen K; Huang HF; Pan LY; Wu M; Yang JX
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):225-8. PubMed ID: 23866908
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
31. Effects of risk factors for ovarian cancer in women with and without endometriosis.
Phung MT; Muthukumar A; Trabert B; Webb PM; Jordan SJ; Terry KL; Cramer DW; Titus LJ; Risch HA; Doherty JA; Harris HR; Goodman MT; Modugno F; Moysich KB; Jensen A; Kjaer SK; Anton-Culver H; Ziogas A; Berchuck A; Khoja L; Wu AH; Pike MC; Pearce CL; Lee AW
Fertil Steril; 2022 Nov; 118(5):960-969. PubMed ID: 36182623
[TBL] [Abstract][Full Text] [Related]
32. Perineal talc use and ovarian cancer: a critical review.
Muscat JE; Huncharek MS
Eur J Cancer Prev; 2008 Apr; 17(2):139-46. PubMed ID: 18287871
[TBL] [Abstract][Full Text] [Related]
33. [Endometriosis-associated ovarian cancers: pathogenesis and consequences on daily practice].
Borghese B; Santulli P; Vaiman D; Alexandre J; Goldwasser F; Chapron C
J Gynecol Obstet Biol Reprod (Paris); 2013 Jun; 42(4):325-33. PubMed ID: 23578493
[TBL] [Abstract][Full Text] [Related]
34. Talc in normal and malignant ovarian tissue.
Henderson WJ; Hamilton TC; Griffiths K
Lancet; 1979 Mar; 1(8114):499. PubMed ID: 85089
[No Abstract] [Full Text] [Related]
35. Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary.
Norris HJ
Int J Gynecol Pathol; 1993 Apr; 12(2):134-40. PubMed ID: 8463037
[TBL] [Abstract][Full Text] [Related]
36. A meta-analytical approach examining the potential relationship between talc exposure and ovarian cancer.
Gross AJ; Berg PH
J Expo Anal Environ Epidemiol; 1995; 5(2):181-95. PubMed ID: 7492905
[TBL] [Abstract][Full Text] [Related]
37. Perineal use of talc and risk of ovarian cancer.
Langseth H; Hankinson SE; Siemiatycki J; Weiderpass E
J Epidemiol Community Health; 2008 Apr; 62(4):358-60. PubMed ID: 18339830
[TBL] [Abstract][Full Text] [Related]
38. Selected topics in peritoneal pathology.
Baker PM; Clement PB; Young RH
Int J Gynecol Pathol; 2014 Jul; 33(4):393-401. PubMed ID: 24901399
[TBL] [Abstract][Full Text] [Related]
39. Malignant endometrioid adenofibroma of the ovary with serous cystadenoma.
Iwasaki I; Yu TJ; Takahashi A
Acta Pathol Jpn; 1986 Apr; 36(4):571-6. PubMed ID: 3728014
[TBL] [Abstract][Full Text] [Related]
40. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
